PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1476368
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1476368
Enteral Feeding Formulas Market Forecasts to 2030 - Global Analysis By Product, Stage, End User and By Geography
According to Stratistics MRC, the Global Enteral Feeding Formulas Market is accounted for $5.8 billion in 2023 and is expected to reach $12.6 billion by 2030 growing at a CAGR of 11.7% during the forecast period. The enteral feeding formulas market encompasses a range of specialized liquid nutrition products designed to meet the nutritional needs of individuals who are unable to consume food orally. These formulas are administered directly into the gastrointestinal tract through feeding tubes, bypassing the oral cavity. The enteral feeding formulas market serves a diverse range of patients, including the elderly, critically ill, and individuals with disabilities.
According to the IDF 2021, approximately 537 million adults are living with diabetes, and the number of people adults living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
Market Dynamics:
Driver:
Increasing prevalence of chronic diseases
As conditions such as cancer, gastrointestinal disorders, and neurological disorders become more prevalent globally, the demand for enteral nutrition solutions rises. These conditions often result in patients experiencing difficulty in swallowing or digesting solid food, necessitating alternative feeding methods like enteral nutrition. Enteral feeding formulas offer a convenient and effective way to deliver essential nutrients directly into the gastrointestinal tract, bypassing the oral route.
Restraint:
High cost of specialized formulas
These formulas are tailored to meet the nutritional needs of individuals with specific medical conditions or dietary requirements, such as those with gastrointestinal disorders, metabolic diseases, or recovering from surgery. However, the exorbitant prices of these specialized formulas make them financially inaccessible to many patients, leading to decreased demand and hindering market expansion. However, healthcare facilities and insurers often face budget constraints, further limiting their ability to procure these costly formulas for patients in need.
Opportunity:
Growing prevalence of malnutrition
Malnutrition is a widespread issue globally, affecting individuals across various age groups due to factors such as chronic illnesses, aging populations, and inadequate dietary intake. Enteral feeding formulas provide a crucial solution for delivering essential nutrients directly to individuals who are unable to consume food orally or absorb nutrients effectively. With the rising awareness about the importance of nutrition in healthcare, coupled with advancements in medical technology and increasing healthcare expenditure, the demand for enteral feeding formulas is on the rise.
Threat:
Lack of patient awareness and insufficient reimbursements for enteral nutrition
Many individuals requiring enteral nutrition support may not fully understand the importance of proper nutrition or the availability of specialized formulas tailored to their needs. This lack of awareness leads to underutilization of enteral feeding products, thereby hindering market growth. Insufficient reimbursements for enteral nutrition are significantly hindering the Enteral Feeding Formulas Market. Enteral nutrition, a critical component of medical care for individuals unable to consume food orally, relies heavily on reimbursements from healthcare systems or insurance providers.
Covid-19 Impact:
Disruptions in the global supply chain led to shortages of raw materials and ingredients essential for manufacturing these formulas, resulting in production delays and supply chain constraints. Lockdown measures and restrictions on non-essential medical procedures reduced hospital admissions and elective surgeries, leading to a decline in the number of patients requiring enteral nutrition support. However, as healthcare systems adapted to the pandemic and began to address the backlog of postponed procedures, the demand for enteral feeding formulas may have gradually rebounded, albeit with ongoing uncertainties regarding future waves of the virus and potential disruptions to healthcare services.
The Disease-specific Formula segment is expected to be the largest during the forecast period
Disease-specific Formula segment is expected to be the largest during the forecast period by catering to the specific nutritional needs of patients with various medical conditions. These specialized formulas are formulated to address the unique dietary requirements of individuals suffering from diseases such as diabetes, cancer, gastrointestinal disorders, and renal failure, among others. By providing tailored nutrition, these formulas optimize patient outcomes, promote faster recovery, and improve overall health management.
The Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period
Long Term Care Facilities segment is expected to have the highest CAGR during the forecast period. As LTCFs cater to individuals with chronic illnesses, disabilities, or those who are unable to consume food orally, the demand for enteral feeding formulas within these facilities is consistently high. These facilities often house elderly individuals with conditions such as dysphagia, dementia, or stroke, who require tailored nutritional support. Consequently, LTCFs represent a crucial market segment driving the development and innovation of enteral feeding formulas, prompting manufacturers to invest in research and development to meet the specific nutritional needs and preferences of this demographic.
Region with largest share:
Asia Pacific region commanded the largest share of the market over the extrapolated period. Preterm infants often require specialized nutritional support due to their underdeveloped gastrointestinal systems, making enteral feeding formulas a vital component of their care. With an increasing number of preterm births, there's a growing demand for high-quality, nutrient-rich enteral feeding formulas tailored to the unique needs of premature infants in the region. This surge in demand has prompted healthcare providers and facilities to procure a greater volume of enteral feeding formulas, thereby driving regional growth.
Region with highest CAGR:
Europe region is poised to hold profitable growth during the forecast period. Stringent regulatory frameworks such as the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) set standards for the production, labeling, and distribution of enteral feeding formulas. These regulations mandate thorough testing, ingredient transparency, and adherence to specific nutritional guidelines. Moreover, reimbursement policies implemented by European governments for enteral nutrition products further stimulate market growth by facilitating access for patients in need.
Key players in the market
Some of the key players in Enteral Feeding Formulas market include Danone S.A, Primus Pharmaceuticals, Inc, Fresenius Kabi AG, Meiji Holdings. Co., Ltd, Abbott, Hormel Foods Corporation, Mead Johnson & Company, LLC, Nestle, B. Braun Melsungen AG, Nutritional Medicinals, LLC, Medtrition Inc and DermaRite Industries, LLC.
Key Developments:
In September 2023, Abbott announced the plan to boost manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
In February 2023, Nestle and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake
In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.
In September 2022, Kate Farms raised USD 75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.
Products Covered:
- Standard Formula
- Disease-specific Formula
- Other Products
Stages Covered:
- Pediatric
- Adult
End Users Covered:
- Hospitals
- Home Care
- Long Term Care Facilities
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Enteral Feeding Formulas Market, By Product
- 5.1 Introduction
- 5.2 Standard Formula
- 5.3 Disease-specific Formula
- 5.3.1 Alzheimer's Disease
- 5.3.2 Cancer Care
- 5.3.3 Malabsorption
- 5.3.4 Diabetes
- 5.3.5 Orphan Diseases
- 5.3.6 Chronic Kidney Diseases
- 5.4 Other Products
6 Global Enteral Feeding Formulas Market, By Stage
- 6.1 Introduction
- 6.2 Pediatric
- 6.3 Adult
7 Global Enteral Feeding Formulas Market, By End User
- 7.1 Introduction
- 7.2 Hospitals
- 7.3 Home Care
- 7.4 Long Term Care Facilities
- 7.5 Other End Users
8 Global Enteral Feeding Formulas Market, By Geography
- 8.1 Introduction
- 8.2 North America
- 8.2.1 US
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 Italy
- 8.3.4 France
- 8.3.5 Spain
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 New Zealand
- 8.4.6 South Korea
- 8.4.7 Rest of Asia Pacific
- 8.5 South America
- 8.5.1 Argentina
- 8.5.2 Brazil
- 8.5.3 Chile
- 8.5.4 Rest of South America
- 8.6 Middle East & Africa
- 8.6.1 Saudi Arabia
- 8.6.2 UAE
- 8.6.3 Qatar
- 8.6.4 South Africa
- 8.6.5 Rest of Middle East & Africa
9 Key Developments
- 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 9.2 Acquisitions & Mergers
- 9.3 New Product Launch
- 9.4 Expansions
- 9.5 Other Key Strategies
10 Company Profiling
- 10.1 Danone S.A
- 10.2 Primus Pharmaceuticals, Inc
- 10.3 Fresenius Kabi AG
- 10.4 Meiji Holdings. Co., Ltd
- 10.5 Abbott
- 10.6 Hormel Foods Corporation
- 10.7 Mead Johnson & Company, LLC
- 10.8 Nestle
- 10.9 B. Braun Melsungen AG
- 10.10 Nutritional Medicinals, LLC
- 10.11 Medtrition Inc
- 10.12 DermaRite Industries, LLC
List of Tables
- Table 1 Global Enteral Feeding Formulas Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 3 Global Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 4 Global Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 5 Global Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 6 Global Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 7 Global Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 8 Global Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 9 Global Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 10 Global Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 11 Global Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 12 Global Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 13 Global Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 14 Global Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 15 Global Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 16 Global Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 17 Global Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 18 Global Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 19 Global Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 20 North America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
- Table 21 North America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 22 North America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 23 North America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 24 North America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 25 North America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 26 North America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 27 North America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 28 North America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 29 North America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 30 North America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 31 North America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 32 North America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 33 North America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 34 North America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 35 North America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 36 North America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 37 North America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 38 North America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 39 Europe Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
- Table 40 Europe Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 41 Europe Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 42 Europe Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 43 Europe Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 44 Europe Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 45 Europe Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 46 Europe Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 47 Europe Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 48 Europe Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 49 Europe Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 50 Europe Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 51 Europe Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 52 Europe Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 53 Europe Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 54 Europe Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 55 Europe Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 56 Europe Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 57 Europe Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 58 Asia Pacific Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
- Table 59 Asia Pacific Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 60 Asia Pacific Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 61 Asia Pacific Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 62 Asia Pacific Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 63 Asia Pacific Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 64 Asia Pacific Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 65 Asia Pacific Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 66 Asia Pacific Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 67 Asia Pacific Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 68 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 69 Asia Pacific Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 70 Asia Pacific Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 71 Asia Pacific Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 72 Asia Pacific Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 73 Asia Pacific Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 74 Asia Pacific Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 75 Asia Pacific Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 76 Asia Pacific Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 77 South America Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
- Table 78 South America Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 79 South America Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 80 South America Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 81 South America Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 82 South America Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 83 South America Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 84 South America Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 85 South America Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 86 South America Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 87 South America Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 88 South America Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 89 South America Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 90 South America Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 91 South America Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 92 South America Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 93 South America Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 94 South America Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 95 South America Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 96 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Country (2021-2030) ($MN)
- Table 97 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Product (2021-2030) ($MN)
- Table 98 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Standard Formula (2021-2030) ($MN)
- Table 99 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Disease-specific Formula (2021-2030) ($MN)
- Table 100 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
- Table 101 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Cancer Care (2021-2030) ($MN)
- Table 102 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Malabsorption (2021-2030) ($MN)
- Table 103 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Diabetes (2021-2030) ($MN)
- Table 104 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Orphan Diseases (2021-2030) ($MN)
- Table 105 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Chronic Kidney Diseases (2021-2030) ($MN)
- Table 106 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other Products (2021-2030) ($MN)
- Table 107 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Stage (2021-2030) ($MN)
- Table 108 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Pediatric (2021-2030) ($MN)
- Table 109 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Adult (2021-2030) ($MN)
- Table 110 Middle East & Africa Enteral Feeding Formulas Market Outlook, By End User (2021-2030) ($MN)
- Table 111 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 112 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Home Care (2021-2030) ($MN)
- Table 113 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Long Term Care Facilities (2021-2030) ($MN)
- Table 114 Middle East & Africa Enteral Feeding Formulas Market Outlook, By Other End Users (2021-2030) ($MN)
